Calliditas Therapeutics AB Finance Income
Calliditas Therapeutics AB reported Finance Income of SEK 30.39 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-24.
Discontinued › Income Statement › Other Income
ifrs-full:FinanceIncome · last filed 2024-04-24
| Period end | Finance Income 12 month |
|---|---|
| 2023-12-31 | 30.39M SEK 20-F · filed 2024-04-24 |
| 2022-12-31 | 50.20M SEK 20-F · filed 2024-04-24 |
| 2021-12-31 | 20.34M SEK 20-F · filed 2024-04-24 |
| 2020-12-31 | 547.00K SEK 20-F · filed 2023-04-26 |
| 2019-12-31 | 926.00K SEK 20-F · filed 2022-04-27 |
| 2018-12-31 | 441.00K SEK 20-F/A · filed 2022-01-14 |